Vakaramoko Diaby to Cross-Sectional Studies
This is a "connection" page, showing publications Vakaramoko Diaby has written about Cross-Sectional Studies.
Connection Strength
0.400
-
Sanogo V, Chen Z, Almutairi RD, Hong X, Diaby V. Predictors of 30-day readmission, mortality, and length of stay for hospitalized U.S. patients with Alzheimer's and related dementias from 2010 to 2015. Expert Rev Pharmacoecon Outcomes Res. 2023 Jun; 23(5):555-559.
Score: 0.126
-
Chen Z, Babcock A, Sanogo V, Nelson DR, Xiao H, Diaby V. Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014. Expert Rev Pharmacoecon Outcomes Res. 2022 Apr; 22(3):409-415.
Score: 0.112
-
Babcock A, Moussa RK, Diaby V. Prevalence and effects of suicidal ideation diagnosis code position in claims on readmission rate estimates. Res Social Adm Pharm. 2021 06; 17(6):1174-1180.
Score: 0.106
-
Chang CY, Park H, Hincapie-Castillo JM, Heldermon CD, Diaby V, Yang S, Wilson DL, Lo-Ciganic WH. Trends, characteristics, race, and ethnicity associated with nonadherence to antidepressants among breast cancer survivors with depression. J Manag Care Spec Pharm. 2023 Apr; 29(4):431-445.
Score: 0.032
-
Shah CH, Balkrishnan R, Diaby V, Xiao H. Examining factors associated with adherence to hormonal therapy in breast cancer patients. Res Social Adm Pharm. 2020 04; 16(4):574-582.
Score: 0.024